News
Spironolactone Use Not Linked to Increased Risk for Cancer
No significant associations seen for spironolactone with risk for breast, ovarian, bladder, kidney, gastric, esophageal cancers
Your search for Spironolactone returned 2 results
News
SGLT2 Inhibitors, MRA Compared for Diabetic Kidney Disease
Evidence in favor of SGLT2 inhibitors and nonsteroidal mineralocorticoid receptor antagonists for treating patients with diabetic kidney disease is growing.
